ARCHIVES

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

This article is from The Cancer Letter archive.

Vol. 26 No. 44 | December 1, 2000

Download PDF Visit The Full Archive

Related Articles

Suit Against Craig Thompson Settled As Company He Co-Founded Licenses “Newly Identified” Discoveries From UPenn

September 14, 2012

Niederhuber Outlines NCI Grant Funding Policies for FY08.

February 8, 2008

MM-121 Study Fails PFS Endpoint, Biomarker Analysis Continues

November 29, 2013

Benefits of Mammography Outweigh Harms In Women with Increased Risk, Starting at Age 40

April 27, 2012

NCAB Committee Approves Recompletion Of Support Contracts

October 7, 1988

In Brief: FDA Names DeLap Directory Of Oncology

June 7, 1996